4//SEC Filing
Olsson Shawn 4
Accession 0001815776-25-000022
CIK 0001815776other
Filed
Apr 8, 8:00 PM ET
Accepted
Apr 9, 7:20 PM ET
Size
7.6 KB
Accession
0001815776-25-000022
Insider Transaction Report
Form 4
Olsson Shawn
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2025-04-09$2.08/sh+1,400$2,912→ 4,733 total - Exercise/Conversion
Stock Option (right to buy)
2025-04-09−1,400→ 63,241 totalExercise: $2.08Exp: 2031-08-18→ Common Stock (1,400 underlying)
Footnotes (1)
- [F1]Shares issued pursuant to the LENZ Therapeutics Operations, Inc. (previously named Lenz Therapeutics, Inc.) 2020 Equity Incentive Plan (the "2020 Plan"). Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2020 Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean April 26, 2021.
Documents
Issuer
LENZ Therapeutics, Inc.
CIK 0001815776
Entity typeother
Related Parties
1- filerCIK 0002015796
Filing Metadata
- Form type
- 4
- Filed
- Apr 8, 8:00 PM ET
- Accepted
- Apr 9, 7:20 PM ET
- Size
- 7.6 KB